Key Metrics
CiteScore 

50.3
Impact Factor 

>= 25
Scite Index 

0.88 5-Year SI

SNIP 

10.66
Recommended pre-submission checks
Powered by 

Topics Covered on The Lancet Infectious Diseases
The Lancet Infectious Diseases Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in The Lancet Infectious Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in The Lancet Infectious Diseases
Secret histories of the HIV epidemic.
- 7 Aug 2026
- The Lancet. Infectious diseases
Congolese hospital staff cohort admitted with infectious symptoms in the setting of the Bundibugyo virus outbreak, April and May 2026, Bunia, DR Congo.
- 3 Aug 2026
- The Lancet. Infectious diseases
Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial.
- 3 Aug 2026
- The Lancet. Infectious diseases
A defining clinical moment during the COVID-19 pandemic in Nigeria.
- 1 Aug 2026
- The Lancet. Infectious diseases
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.
- 1 Aug 2026
- The Lancet. Infectious diseases
Rapid recruitment for a remote long COVID clinical trial.
- 1 Aug 2026
- The Lancet. Infectious diseases
Secret histories of the HIV epidemic.
- 7 Aug 2026
- The Lancet. Infectious diseases
Congolese hospital staff cohort admitted with infectious symptoms in the setting of the Bundibugyo virus outbreak, April and May 2026, Bunia, DR Congo.
- 3 Aug 2026
- The Lancet. Infectious diseases
Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial.
- 3 Aug 2026
- The Lancet. Infectious diseases
A defining clinical moment during the COVID-19 pandemic in Nigeria.
- 1 Aug 2026
- The Lancet. Infectious diseases
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.
- 1 Aug 2026
- The Lancet. Infectious diseases
Rapid recruitment for a remote long COVID clinical trial.
- 1 Aug 2026
- The Lancet. Infectious diseases